US Oncology, Welsh Carson Portfolio Company, Sells For 9x: Updated

It’s Monday and we have a relatively large health care deal. McKesson Corp. announced today that it was buying US Oncology, a Welsh Carson portfolio company, for $2.16 billion, including debt. US Oncology has about $1.6 billion in debt, according to an August 10Q filing, which values the sale at about $560 million. The company had $28.1 million in income from operations for the quarter ended June 30, down nearly 24% from about $36.8 million for the same time period in 2009. US Oncology posted a net loss of about $12 million for the quarter ended June 30, which narrowed from $16.4 million in losses in 2009.

DealsNorth AmericaUS